William P. Sheridan
2017
In 2017, William P. Sheridan earned a total compensation of $1.8M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 121% increase compared to previous year.
Compensation breakdown
| Bonus | $155,618 |
|---|---|
| Non-Equity Incentive Plan | $141,429 |
| Option Awards | $1,001,288 |
| Salary | $469,143 |
| Other | $41,072 |
| Total | $1,808,550 |
Sheridan received $1M in option awards, accounting for 55% of the total pay in 2017.
Sheridan also received $155.6K in bonus, $141.4K in non-equity incentive plan, $469.1K in salary and $41.1K in other compensation.
Rankings
In 2017, William P. Sheridan's compensation ranked 5,994th out of 14,666 executives tracked by ExecPay. In other words, Sheridan earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,994 out of 14,666 | 59th |
Division Manufacturing | 2,198 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 690 out of 2,075 | 67th |
Industry group Drugs | 533 out of 1,731 | 69th |
Industry Biological Products, Except Diagnostic Substances | 97 out of 313 | 69th |
Source: SEC filing on May 10, 2018.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2017.
2017
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2017
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2017
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2017
Lynne Powell
BioCryst Pharmaceuticals